2026-01-26 - Analysis Report
**Ventas, Inc. (VTR) Analysis Report**
=====================================

### Company Overview
Ventas, Inc. is a healthcare real estate investment trust (REIT) that invests in and operates various types of healthcare and senior living facilities.

### Return Rate Comparison
* Review Stock (VTR): 74.11%
* Comparison Stock (S&P 500, VOO): 126.41%
* Divergence: -53.30 (relatively low, but improving)

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 4.0% | 20.6% | -8.0% | 0.4 | 27.5B |
| 2017-2019  | 5.0% | 22.7% | -20.0% | 0.2 | 27.1B |
| 2018-2020  | 10.0% | 74.7% | -14.0% | 1.3 | 23.0B |
| 2019-2021  | -7.0% | 74.7% | -73.0% | 1.4 | 24.0B |
| 2020-2022  | -7.0% | 72.4% | -14.0% | 1.3 | 21.2B |
| 2021-2023  | 16.0% | 36.8% | -5.0% | 0.8 | 23.4B |
| 2022-2024  | 23.0% | 36.8% | -7.0% | 0.7 | 27.7B |
| 2023-2025  | 64.0% | 20.3% | -11.0% | 0.5 | 36.4B |

### Recent Stock Price Fluctuations
* Close: $76.99
* Last-market change: 0.54 (0.7% increase)
* 5-day SMA: $77.60
* 20-day SMA: $77.26
* 60-day SMA: $77.63

### RSI, PPO Index Indicators
* Market Risk Indicator (MRI): 0.70
* RSI: 47.96
* PPO: 0.09
* Recent (20 days) relative divergence change: improving
* 7-day Rank change: flat
* 7-day Dynamic Expected Return change: flat

### Expected Return
* Expected Return (%): -116.00% (expected excess return compared to S&P 500 if invested long-term)

### Recent News & Significant Events
* Y Intercept Hong Kong Ltd Raises Stock Position in Ventas, Inc. $VTR
* Ventas Stock Gains 10.9% in Three Months: Will it Continue to Rise?
* Ventas Inc (NYSE:VTR) Emerges as a High-Growth Momentum Candidate After Sideways Consolidation
* Ventas Stock Gains 10.9% in Three Months: Will it Continue to Rise?
* Ventas, Inc. $VTR Shares Acquired by Teacher Retirement System of Texas
* VTR Stock Falls -5.2% With 7-day Losing Spree On C-Suite Stock Sales

### Analyst Opinions
* Analyst Consensus:
	+ Key: Buy
	+ Mean (1=StrongBuy~5=Sell): 1.52 (~Buy)
	+ Opinions: 20
	+ Target Price (avg/high/low): 85.65 / 94.00 / 75.00

### Recent Earnings Analysis
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-30 | 0.14 | 1.49 B$ |
| 2025-07-31 | 0.15 | 1.42 B$ |
| 2025-05-01 | 0.11 | 1.36 B$ |
| 2024-10-31 | 0.05 | 1.24 B$ |
| 2025-10-30 | 0.05 | 1.24 B$ |

### Financial Information
#### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $1.49B | 41.58% |
| 2025-06-30 | $1.42B | 41.80% |
| 2025-03-31 | $1.36B | 42.15% |
| 2024-12-31 | $1.29B | 42.42% |
| 2024-09-30 | $1.24B | 42.17% |

#### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $12.36B | 0.53% |
| 2025-06-30 | $11.53B | 0.59% |
| 2025-03-31 | $11.47B | 0.41% |
| 2024-12-31 | $10.77B | 0.53% |
| 2024-09-30 | $9.76B | 0.20% |

### Comprehensive Analysis
Ventas, Inc. (VTR) has shown a moderate level of performance, with a cumulative return of 74.11% compared to the S&P 500's 126.41%. The company has a relatively low risk profile, with an MRI of 0.70. The RSI and PPO indicators suggest a neutral market sentiment, while the recent news and events suggest a positive outlook for the company.

The analyst consensus is bullish, with 1.52 as the mean opinion rating and a target price range of 85.65 to 94.00. The recent earnings analysis suggests a stable revenue growth, with a slight decline in net income.

Overall, VTR appears to be a solid investment opportunity, but investors should exercise caution and consider the potential risks and challenges facing the company.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.